Ho DD - Search Results

1

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.

Cao Y, Qin L, Zhang L, Safrit J, Ho DD. Cao Y, et al. Among authors: ho dd. N Engl J Med. 1995 Jan 26;332(4):201-8. doi: 10.1056/NEJM199501263320401. N Engl J Med. 1995. PMID: 7808485 Free article.

2

Discontinuous epitopes on gp120 important in HIV-1 neutralization.

Ho DD, Fung MS, Yoshiyama H, Cao Y, Robinson JE. Ho DD, et al. AIDS Res Hum Retroviruses. 1992 Aug;8(8):1337-9. doi: 10.1089/aid.1992.8.1337. AIDS Res Hum Retroviruses. 1992. PMID: 1281654 No abstract available.

3

Identification and quantitation of HIV-1 in the liver of patients with AIDS.

Cao YZ, Dieterich D, Thomas PA, Huang YX, Mirabile M, Ho DD. Cao YZ, et al. Among authors: ho dd. AIDS. 1992 Jan;6(1):65-70. doi: 10.1097/00002030-199201000-00008. AIDS. 1992. PMID: 1543567

4

Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody.

Ho DD, Fung MS, Cao YZ, Li XL, Sun C, Chang TW, Sun NC. Ho DD, et al. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8949-52. doi: 10.1073/pnas.88.20.8949. Proc Natl Acad Sci U S A. 1991. PMID: 1717992 Free PMC article.

5

Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection.

Daar ES, Moudgil T, Meyer RD, Ho DD. Daar ES, et al. Among authors: ho dd. N Engl J Med. 1991 Apr 4;324(14):961-4. doi: 10.1056/NEJM199104043241405. N Engl J Med. 1991. PMID: 1823118 Free article.

6

HIV-1 neutralizing antibodies in urine from seropositive individuals.

Cao YZ, Friedman-Kien AE, Mirabile M, Li XL, Alam M, Dieterich D, Ho DD. Cao YZ, et al. Among authors: ho dd. J Acquir Immune Defic Syndr (1988). 1990;3(3):195-9. J Acquir Immune Defic Syndr (1988). 1990. PMID: 1968094

7

CD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro.

Cao YZ, Friedman-Kien AE, Huang YX, Li XL, Mirabile M, Moudgil T, Zucker-Franklin D, Ho DD. Cao YZ, et al. Among authors: ho dd. J Virol. 1990 Jun;64(6):2553-9. doi: 10.1128/JVI.64.6.2553-2559.1990. J Virol. 1990. PMID: 2159530 Free PMC article.

8

Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.

Ho DD, Moudgil T, Alam M. Ho DD, et al. N Engl J Med. 1989 Dec 14;321(24):1621-5. doi: 10.1056/NEJM198912143212401. N Engl J Med. 1989. PMID: 2586564

9

Safety, pharmacokinetics, and antiviral activity of A77003, a C2 symmetry-based human immunodeficiency virus protease inhibitor.

Reedijk M, Boucher CA, van Bommel T, Ho DD, Tzeng TB, Sereni D, Veyssier P, Jurriaans S, Granneman R, Hsu A, et al. Reedijk M, et al. Among authors: ho dd. Antimicrob Agents Chemother. 1995 Jul;39(7):1559-64. doi: 10.1128/AAC.39.7.1559. Antimicrob Agents Chemother. 1995. PMID: 7492104 Free PMC article. Clinical Trial.

10

Biological characterization of nef in long-term survivors of human immunodeficiency virus type 1 infection.

Huang Y, Zhang L, Ho DD. Huang Y, et al. Among authors: ho dd. J Virol. 1995 Dec;69(12):8142-6. doi: 10.1128/JVI.69.12.8142-8146.1995. J Virol. 1995. PMID: 7494338 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

464 results

Search Page

Filters